The aglycone constituents of CARDIAC GLYCOSIDES. The ring structure is basically a cyclopentanoperhydrophenanthrene nucleus attached to a lactone ring at the C-17 position.
|Drug||Drug Name||Drug Indication|
|DB00390||Digoxin||Digoxin is indicated in the following conditions: 1) For the treatment of mild to moderate heart failure in adult patients.[L6775] 2) To increase myocardial contraction in children diagnosed with heart failure.[L6775] 3) To maintain control ventricular rate in adult patients diagnosed with chronic atrial fibrillation.[L6775] In adults with heart failure, when it is clinically possible, digoxin should be administered in conjunction with a diuretic and an angiotensin-converting enzyme (ACE) inhibitor for optimum effects.[L6775]|
|DB00511||Acetyldigitoxin||Used for fast digitalization in congestive heart failure.|
|DB01078||Deslanoside||For the treatment and management of Congestive cardiac insufficiency, arrhythmias and heart failure.|
|DB01092||Ouabain||For the treatment of atrial fibrillation and flutter and heart failure|
|DB01396||Digitoxin||For the treatment and management of congestive cardiac insufficiency, arrhythmias and heart failure.|
|DB13467||Lanatoside C||Not Available|